A
37.63
-0.11 (-0.29%)
| Previous Close | 37.74 |
| Open | 37.57 |
| Volume | 214,231 |
| Avg. Volume (3M) | 297,977 |
| Market Cap | 1,717,960,064 |
| Price / Earnings (TTM) | 28.95 |
| Price / Sales | 1.05 |
| Price / Book | 2.45 |
| 52 Weeks Range | |
| Earnings Date | 25 Feb 2025 - 3 Mar 2025 |
| Profit Margin | 3.63% |
| Operating Margin (TTM) | 5.94% |
| Diluted EPS (TTM) | 1.30 |
| Quarterly Revenue Growth (YOY) | 37.50% |
| Quarterly Earnings Growth (YOY) | -27.00% |
| Total Debt/Equity (MRQ) | 93.87% |
| Current Ratio (MRQ) | 1.91 |
| Operating Cash Flow (TTM) | 82.45 M |
| Levered Free Cash Flow (TTM) | 124.77 M |
| Return on Assets (TTM) | 4.49% |
| Return on Equity (TTM) | 10.26% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | Astrana Health Inc. | Bullish | - |
AIStockmoo Score
1.1
| Analyst Consensus | 5.0 |
| Insider Activity | -1.5 |
| Price Volatility | 2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.5 |
| Average | 1.10 |
|
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Growth |
| % Held by Insiders | 23.70% |
| % Held by Institutions | 46.03% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Steelpeak Wealth, Llc | 30 Sep 2024 | 679,984 |
| Northcrest Asset Manangement, Llc | 30 Sep 2024 | 460,895 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 86.00 (Baird, 128.54%) | Buy |
| Median | 70.00 (86.02%) | |
| Low | 66.00 (TD Cowen, 75.39%) | Buy |
| Average | 74.00 (96.65%) | |
| Total | 3 Buy | |
| Avg. Price @ Call | 53.68 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Baird | 13 Nov 2024 | 86.00 (128.54%) | Buy | 41.91 |
| TD Cowen | 14 Oct 2024 | 66.00 (75.39%) | Buy | 59.64 |
| BTIG | 03 Oct 2024 | 70.00 (86.02%) | Buy | 59.48 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| KITAYAMA MITCHELL W | - | 39.47 | -5,100 | -201,297 |
| Aggregate Net Quantity | -5,100 | |||
| Aggregate Net Value ($) | -201,297 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 39.47 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| KITAYAMA MITCHELL W | Director | 10 Dec 2024 | Disposed (-) | 5,100 | 39.47 | 201,297 |
| Date | Type | Details |
|---|---|---|
| 19 Dec 2024 | Announcement | Astrana Health, Inc. to Participate in Upcoming Investor Conference |
| 21 Nov 2024 | Announcement | Astrana Health Provider Groups Recognized with Highest Elite Status in America's Physician Groups 2024 Standards of Excellence™ Survey |
| 08 Nov 2024 | Announcement | Astrana Health Announces Definitive Agreement to Acquire Certain Businesses and Assets of Prospect Health System |
| 07 Nov 2024 | Announcement | Astrana Health, Inc. Reports Third Quarter 2024 Results |
| 23 Oct 2024 | Announcement | Astrana Health, Inc. Schedules 2024 Third Quarter Financial Results Release and Conference Call |
| 07 Oct 2024 | Announcement | Astrana Health Completes Acquisition of Collaborative Health Systems |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |